Rethinking Ligand Efficiency: Normalization Pitfalls, Uncertainty, and State-Invariant Metrics
Ligand efficiency (LE), defined as the negative binding free energy per heavy atom, is a widely used metric in medicinal chemistry. Yet its mathematical construction embeds a strong size bias that distorts cross-size comparisons, and size-independent variants inherit sensitivity to the arbitrary choice of standard state. This study reviews normalization pitfalls, addresses uncertainty propagation, and introduces a state-invariant, size-normalized metric for efficiency-guided optimization from fragments to leads.
Authors
- Hongtao Zhao (ORCID: https://orcid.org/0000-0002-9318-1052)
Institutions
- AstraZeneca (Brazil) (BR)
- Medicina (PL)
- AstraZeneca (Sweden) (SE)
Publication Details
- Journal
- ACS Medicinal Chemistry Letters
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1021/acsmedchemlett.5c00652
- Citations
- 1
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 1.50